Liraglutide pharmacokinetics and exposure‐response in adolescents with obesity-Reference-Cited by-同舟云学术

Liraglutide pharmacokinetics and exposure‐response in adolescents with obesity

Author:

Carlsson Petri Kristin C.¹^ORCID,Hale Paula M.²,Hesse Dan³,Rathor Naveen⁴,Mastrandrea Lucy D.⁵

Affiliation:

1. Department of Quantitative Clinical Pharmacology Novo Nordisk A/S Søborg Denmark

2. Clinical Development, Medical & Regulatory Affairs Novo Nordisk Inc Plainsboro New Jersey USA

3. Department of Medical & Science – Obesity and Metabolism Novo Nordisk A/S Søborg Denmark

4. Department of Global Medical Affairs Novo Nordisk A/S Søborg Denmark

5. Division of Pediatric Endocrinology/Diabetes, Jacobs School of Medicine and Biomedical Sciences University at Buffalo Buffalo New York USA

Funder

Novo Nordisk

Publisher

Wiley

Subject

Public Health, Environmental and Occupational Health,Nutrition and Dietetics,Health Policy,Pediatrics, Perinatology, and Child Health

Link

Reference41 articles.

1. Childhood and adolescent obesity in the United States: a public health concern;Sanyaolu A;Glob Pediatr Health,2019

2. Prevalence of obesity among adults and youth: United States, 2015‐2016;Hales CM;NCHS Data Brief,2017

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献